Navigation Links
Breast Cancer Patient First in Latin America to Receive Treatment Using Elekta VMAT Planned with Monaco Software
Date:7/2/2010

MONTERREY, Mexico and ATLANTA, July 2 /PRNewswire/ -- A 64-year-old female patient with mediastinal metastasis recently became the first in Latin America to receive Elekta VMAT radiotherapy treatment enhanced with Monaco® planning software. Using the arc-based Elekta VMAT delivery method, Monaco displays how the radiation dose should be applied — its distribution and strength on the target. The result is a therapy that not only is rapid, but also fine-tuned to treat cancer and avoid healthy tissues.

The patient completed her five Elekta VMAT treatment sessions at OCA Hospital, each of which lasted less than five minutes*. The largest private medical center in Mexico, OCA Hospital is the fifth center in the world to utilize the combined radiation therapy planning and delivery solution.

Since, OCA Hospital has used the technique to treat four additional patients: one with parotid cancer, a patient with a gastrointestinal stromal (GIST) tumor, a third patient with rectal cancer and a patient with prostate cancer.

"The speed of Elekta VMAT is reinforced with sophisticated Monaco planning, which helps us effectively plan around targets and organs-at-risk," says Genaro Levinson, president and CEO of OCA Hospital. "Also, the Monte Carlo dose algorithm enhances the predictability of the dose, so we can confidently deliver the highest therapeutic dose."

A key feature of Monaco is the Monte Carlo dose engine, which ensures the greatest possible therapeutic radiation hits the cancer target, while minimizing the dose to normal healthy tissues.

In addition to its Elekta VMAT/Monaco first, OCA Hospital was the first medical center in Latin America to install Elekta Synergy®, a treatment system equipped with advanced imaging technology to visualize the tumor and critical structures with the patient in the treatment position at the time of treatment.

"OCA leadership and senior management determined to upgrade our oncology department with state-of-the-art technology, including how we could improve Elekta Synergy," Levinson says. "We wanted to be one step ahead of Intensity Modulated Radiation Therapy [IMRT] with static segments, which we had been doing successfully for years. We envisioned VMAT as an excellent alternative for dynamic IMRT using rapid volumetric arcs."

To learn more about Monaco planning software, visit www.elekta.com/monacovmat.

*Actual treatment times may vary.

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.

About OCA Hospital

OCA Hospital is among the most advanced cancer treatment centers in the world. From early diagnosis with its PET-CT system, to the most precise therapeutic treatments (IMRT, VMAT), conducted with state-of-the-art radiation therapy systems, OCA Hospital gives its patients access to the most sophisticated medical technology available.

OCA Hospital is Latin America's only hospital that produces 10 different radioisotopes in its radiopharmacy and cyclotron lab — for more specificity in diagnosing a variety of tumors.


'/>"/>
SOURCE Elekta
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hoag Breast Care Center Installs Xoft Electronic Brachytherapy System for IORT Program
2. Pink Lotus Breast Center to Integrate Electronic Brachytherapy Cancer Treatment Platform
3. Society of Nuclear Medicine Releases New Guidelines for Breast-Specific Gamma Imaging
4. TechniScan Announces Adding Another Center to Worldwide Clinical Trials for New Breast Imaging System
5. Karmanos Cancer Institute Researchers Study Bisphosphonates and Their Affect on Early Stage Breast Cancer
6. Syndax Pharmaceuticals Entinostat Shows Clinical Promise in Patients with Advanced Hormone Refractory Breast Cancer
7. Karmanos Cancer Institutes Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool
8. Patent Awarded to the Design of TechniScans Unique 3-D Breast Imaging System
9. Medela Helps Employers Create Supportive Environment for Breastfeeding
10. BSGI Offers Clear View of Breast Tumor Response to Neoadjuvant Chemotherapy
11. 12 Month Follow-Up Data for Isotope-Free Breast IORT Presented at ASBS Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
(Date:5/25/2016)... 25, 2016 As illustrated by ... this month, the numbers and momentum of cannabis in ... into the billions, more research and development push the ... State of Legal Marijuana Markets Report  from from ArcView ... much of the increase in sector is attributed to ...
(Date:5/25/2016)... , May 25, 2016 ... the precision of circulating tumour DNA (ctDNA) analysis ... the appointment of Professor Clive Morris ... leadership across the clinical development programme, scientific collaborations, ... help deliver significant improvements in clinical outcomes for ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... with discovery of thousands of defective respirators, according to court documents and SEC ... case of William and Becky Tyler v. American Optical Corporation, Case No. BC588866, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, ... as a partner for the Tamika Catchings Legacy Tour that will commemorate ... leader in hardwood basketball surfaces in all forms and levels of the game, Connor ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent Pharma Solutions, the ... consumer health and global clinical supply services, today announced two key appointments and ... continued investment and strategic growth plans in the Asia Pacific region. , Howard ...
Breaking Medicine News(10 mins):